Prof. Dr. Ralf Gilsbach
| Beruflicher Werdegang | |
| Seit 2022 | Full (W3) and DZHK-Professor, Institute of Experimental Cardiology, Internal Medicine VIII, Heidelberg University Hospital, Medical Faculty, Heidelberg University |
| 2019-2022 | Associate (W2) Professor, Institute of Cardiovascular Physiology, Medical Faculty, Goethe University Frankfurt |
| 2012-2019 | Group leader, Institute of Experimental and Clinical Pharmacology and Toxicology, Medical Faculty, University of Freiburg |
| 2006-2012 | Postdoc, Institute of Experimental and Clinical Pharmacology and Toxicology, Medical Faculty, University of Freiburg |
| 2001-2006 | Scientist and PhD student, Institute of Pharmacology and Toxicology, Medical Faculty, University of Bonn |
| Wissenschaftlicher Werdegang | |
| 2012 | Habilitation in Pharmacology and Toxicology, Medical Faculty, University of Freiburg, Mentor: Prof. Dr. Lutz Hein |
| 2006 | Dr. rer. nat. in Pharmacology and Toxicology (summa cum laude), Faculty of Mathematics and Natural Sciences, University of Bonn, Mentor: Prof. Dr. Heinz Boenisch |
| 2001 | Dipl.-pharm. in Pharmacology and Toxicology, Faculty of Mathematics and Natural Sciences, University of Bonn, Mentor: Prof. Dr. Klaus Mohr |
| 2000-2001 | Graduate education in Pharmacy (Diplom), University of Bonn |
| 1995-2001 | Study of Pharmacy, University of Bonn |
Auszeichnungen und Stipendien Miscellaneous (Honours, Awards, Scholarships, and other scientific distinctions) | |
| 2021 | Faculty member of the International Max Planck Research School for Molecular and Organ Biology (IMPRS-MOB) |
| 2019-2022 | Adjunct Faculty member of the Cardio-Pulmonary Institute (CPI) |
| 2019 | Guido Tarrone Award, Heart Failure Association of the European Society of Cardiology |
| Since 2022 | DZHK-Professor and PI, DZHK Partner Site Heidelberg/Mannheim |
| Wissenschaftliche Schwerpunkte | |
| Epigenetics and chromatin organization of heart disease | |
| Functional epigenetic modulation of disease risk factors | |
| Cell type-specific and single cell analysis | |
| Funding (main) | |
| Since 2023 | DZHK Innovation Cluster grant (with C. Schmidt, and Laura Zelarayán) „AAV-based epigenetic perturbation - from translational disease models to anti-arrhythmic strategies“ |
| Since 2022 | PI CRC1550 "Molecular Circuits of Heart Disease” (Speaker: Johannes Backs, Heidelberg), Project A02 |
| 2021-2022 | Cardio-Pulmonary Institute (CPI) flexible outbreak project grant with T. Braun |
| Since 2020 | PI CRC1425 “ScareCare” (Speaker Peter Kohl, Freiburg), Project P02, S03 |
| 2018-2021 | BW Stiftung, Human-CM-3D-Genome |
| 2019-2020 | DFG research grant “Enhancer-based modulation of cardiac fibroblasts” |
| 2017-2022 | DFG research grant “Chromatin organization dynamics during maturation and pathological hypertrophy of cardiac myocytes” |
| 2008-2014 | DFG joint research grant with L. Hein “Structural remodeling of the sympathetic nervous system in heart disease“ |